TipRanks
Go Ultimate55% OFF

Anthera Pharmaceuticals (ANTH) Income Statement

Anthera Pharmaceuticals Income Statement

Last quarter (Q1 2018), Anthera Pharmaceuticals's total revenue was $0.00. In Q1, Anthera Pharmaceuticals's net income was $-4.43M. See Anthera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 17
$ 0.00
$ -281.00K
$ 36.53M
Depreciation and Amortization$ 281.00K
$ -26.59M
$ -36.43M
$ 9.56M
$ -26.87M
$ -16.93M
Per Share Metrics
Basic EPS$ -1.65
Diluted EPS$ -1.65
Weighted Average Shares Outstanding10.28M
Weighted Average Shares Outstanding (Diluted)10.28M

Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

-18M-12M-6M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017RevenueEarningsProfit Margin